In Vitro Activities of Two Ketolides, HMR 3647 and HMR 3004, against Gram-Positive Bacteria
- 1 April 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (4) , 930-936
- https://doi.org/10.1128/aac.43.4.930
Abstract
The in vitro activities of two new ketolides, HMR 3647 and HMR 3004, were tested by the agar dilution method against 280 strains of gram-positive bacteria with different antibiotic susceptibility profiles, including Staphylococcus aureus , Enterococcus faecalis , Enterococcus faecium , Streptococcus spp. (group A streptococci, group B streptococci, Streptococcus pneumoniae , and alpha-hemolytic streptococci). Seventeen erythromycin-susceptible (Em s ), methicillin-susceptible S. aureus strains were found to have HMR 3647 and HMR 3004 MICs 4- to 16-fold lower than those of erythromycin (MIC at which 50% of isolates were inhibited [MIC 50 ] [HMR 3647 and HMR 3004], 0.03 μg/ml; range, 0.03 to 0.06 μg/ml; MIC 50 [erythromycin], 0.25 μg/ml; range, 0.25 to 0.5 μg/ml). All methicillin-resistant S. aureus strains tested were resistant to erythromycin and had HMR 3647 and HMR 3004 MICs of >64 μg/ml. The ketolides were slightly more active against E. faecalis than against E. faecium , and MICs for individual strains varied with erythromycin susceptibility. The MIC 50 s of HMR 3647 and HMR 3004 against Em s enterococci (MIC ≤ 0.5 μg/ml) and those enterococcal isolates with erythromycin MICs of 1 to 16 μg/ml were 0.015 μg/ml. E. faecalis strains that had erythromycin MICs of 128 to >512 μg/ml showed HMR 3647 MICs in the range of 0.03 to 16 μg/ml and HMR 3004 MICs in the range of 0.03 to 64 μg/ml. In the group of E. faecium strains for which MICs of erythromycin were ≥512 μg/ml, MICs of both ketolides were in the range of 1 to 64 μg/ml, with almost all isolates showing ketolide MICs of ≤16 μg/ml. The ketolides were also more active than erythromycin against group A streptococci, group B streptococci, S. pneumoniae , rhodococci, leuconostocs, pediococci, lactobacilli, and diphtheroids. Time-kill studies showed bactericidal activity against one strain of S. aureus among the four strains tested. The increased activity of ketolides against gram-positive bacteria suggests that further study of these agents for possible efficacy against infections caused by these bacteria is warranted.Keywords
This publication has 26 references indexed in Scilit:
- Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) Compared to Those of Erythromycin, Azithromycin, Clarithromycin, Roxithromycin, and Eight Other Antimicrobial Agents against Unusual Aerobic and Anaerobic Human and Animal Bite Pathogens Isolated from Skin and Soft Tissue Infections in HumansAntimicrobial Agents and Chemotherapy, 1998
- Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effectJournal of Antimicrobial Chemotherapy, 1998
- The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in AdultsClinical Infectious Diseases, 1997
- Antimicrobial activity of RU-66647, a new ketolideDiagnostic Microbiology and Infectious Disease, 1997
- Emerging Resistance to Antimicrobial Agents in Gram-Positive BacteriaDrugs, 1996
- Nosocomial Bloodstream InfectionsArchives of internal medicine (1960), 1995
- Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deathsArchives of internal medicine (1960), 1995
- Quinupristin/Dalfopristin: Spectrum of Activity, Pharmacokinetics, and Initial Clinical ExperienceMicrobial Drug Resistance, 1995
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modificationAntimicrobial Agents and Chemotherapy, 1991